Kumamoto, Japan

Shinichi Maruno

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Km Biologics Co., Ltd.. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shinichi Maruno. Retrieved from https://idiyas.com/inventor/shinichi-maruno

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Shinichi Maruno

Introduction

Shinichi Maruno is a notable inventor based in Kumamoto, Japan. He has made significant contributions to the field of vaccine development, particularly in creating a highly safe dengue vaccine. His work has the potential to impact public health positively by providing effective protection against dengue virus infections.

Latest Patents

Maruno holds a patent for a multivalent dengue vaccine composition. This innovative vaccine comprises a mixture of attenuated dengue viruses from different serotypes. It is designed to induce a neutralizing antibody response against all four serotypes of the dengue virus without developing more than a fixed level of viremia with a single administration. This tetravalent dengue virus formulation is noted for its excellent efficacy and safety.

Career Highlights

Throughout his career, Maruno has been associated with Km Biologics Co., Ltd., where he has focused on vaccine research and development. His dedication to advancing medical science is evident in his innovative approaches to vaccine formulation.

Collaborations

Maruno has collaborated with esteemed colleagues, including Kengo Sonoda and Yasuhiko Shinmura. These partnerships have contributed to the success of his research and the development of his patented vaccine.

Conclusion

Shinichi Maruno's work in developing a safe and effective dengue vaccine highlights his commitment to improving public health through innovation. His contributions to vaccine technology are invaluable and demonstrate the importance of research in combating infectious diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…